Journey Medical Corp (DERM)

EBITDA Growth

257.49%

TTM · Period ending:

DERM logo

DERM EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported257.49%
DERM TTM EBITDA YoY % (8.20% → 257.49%)
High-resolution chart · PNG

DERM ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Journey Medical Corp EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
257.4916%
0.9763%
60.374%
94.7174%
-120.4264%
-213.9905%
-537.064%
-127.9712%
118.0913%
103.9647%
108.287%
72.4699%
-176.78%
-83.2304%
-42.3807%
-242.5232%
-93.9713%
-323.9943%
-282.6658%
87.4785%
90.4921%
106.1397%
75.5109%
69.4806%
39.6765%
-6.2854%
30.7222%
34.4068%
31.8218%
25.8515%
-332.9365%
-444.6363%
-973.1443%
-393.1366%
5.0155%
7.5753%
65.1417%
8.1996%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.